SCHEMBL8083513

SCHEMBL8083513

COc1c(CCCc2ccccc2)[c]c(CCCc2cccs2)c(OC)c1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 2/20 0.41
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MAPT P10636 1/20 0.39
TAAR1 Q96RJ0 1/20 0.38
TSHR P16473 2/20 0.38
TRPV1 Q8NER1 1/20 0.38
BRD4 O60885 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPK1 P28482 1/20 0.36
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9378975 0.99 HPGD (0.40) HPGDSMN1; SMN2LMNARAB9ANPC1
SCHEMBL6567905 0.86 HTR2A (0.41) TDP1
SCHEMBL8091400 0.83 L3MBTL1 (0.44) TDP1
SCHEMBL8090038 0.83 ABCB1 (0.39) TDP1
SCHEMBL8090053 0.80 LTA4H (0.40) KMT2AMEN1TAAR1
SCHEMBL6333918 0.80 TAAR1 (0.57) HPGDSMN1; SMN2LMNARAB9ANPC1
SCHEMBL7434046 0.79 TDP1 (0.51) RAB9ANPC1KMT2AMEN1TDP1
SCHEMBL8090170 0.77 TDP1 (0.49) KMT2AMEN1TDP1
SCHEMBL8921330 0.76 TAAR1 (0.57) HPGDSMN1; SMN2LMNARAB9ANPC1
SCHEMBL8091379 0.75 HTR2A (0.35) LMNATDP1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6124328-A TREATING NERVE CELLS WITH A NEUROTROPHIC AGENT; PROMOTING REPAIR OF NEURONAL DAMAGE CAUSED BY DISEASE OR PHYSICAL TRAUMA VERTEX PHARMACEUTICALS INCORPORATED (US) 2000-09-26 US disclosed
US-6037370-A TREATING ALZHEIMER*S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, PARKINSON*S DISEASE, AND OTHER NERVOUS SYSTEM DISORDERS WITH PEPTIDE DERIVATIVES VERTEX PHARMACEUTICALS INCORPORATED (US) 2000-03-14 US disclosed
EP-0584223-A1 NOVEL IMMUNOSUPPRESSIVE COMPOUNDS VERTEX PHARMACEUTICALS INCORPORATED (US) 1994-03-02 EP disclosed